Literature DB >> 1500537

Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells.

B E Dunn1, T P Monson, J S Dumler, C C Morris, A B Westbrook, J L Duncan, J E Dawson, K G Sims, B E Anderson.   

Abstract

We report a case of ehrlichiosis in a 72-year-old man who developed extreme lethargy, acute renal failure requiring hemodialysis, and respiratory insufficiency requiring intubation. Lumbar puncture performed on the second day of hospitalization revealed significant cellular pleocytosis. Ehrlichia morulae were tentatively identified in mononuclear cells in routinely processed Wright-stained cytospin preparations of cerebrospinal fluid (CSF). Identification was confirmed by a specific immunocytochemical staining procedure. Subsequent identification specifically as Ehrlichia chaffeensis morulae was established by polymerase chain reaction analysis, which revealed E. chaffeensis-specific DNA in CSF, bone marrow, and blood samples; by indirect fluorescent-antibody analysis, the patient developed an antibody titer of 32,768 against E. chaffeensis antigen. The patient responded to intravenous therapy with doxycycline and dexamethasone. Subsequently, neurologic, hematologic, renal, and pulmonary status had returned to baseline at follow-up 12 weeks after admission. To our knowledge, this is the first identification of E. chaffeensis morulae in CSF cells in an infected patient.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500537      PMCID: PMC265474          DOI: 10.1128/jcm.30.8.2207-2210.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Neurologic abnormalities in a patient with human ehrlichiosis.

Authors:  J R Harkess; D Stucky; S A Ewing
Journal:  South Med J       Date:  1990-11       Impact factor: 0.954

2.  Identification of Ehrlichia in human tissue.

Authors:  J S Dumler; P Brouqui; J Aronson; J P Taylor; D H Walker
Journal:  N Engl J Med       Date:  1991-10-10       Impact factor: 91.245

Review 3.  Ehrlichiosis.

Authors:  J R Harkess
Journal:  Infect Dis Clin North Am       Date:  1991-03       Impact factor: 5.982

4.  Lupus anticoagulant, thrombosis, and fetal loss.

Authors:  D I Feinstein
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

5.  Human ehrlichiosis: prospective active surveillance in febrile hospitalized patients.

Authors:  D B Fishbein; A Kemp; J E Dawson; N R Greene; M A Redus; D H Fields
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

Review 6.  Ehrlichiosis--a disease of animals and humans.

Authors:  J E McDade
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

7.  Detection of the etiologic agent of human ehrlichiosis by polymerase chain reaction.

Authors:  B E Anderson; J W Sumner; J E Dawson; T Tzianabos; C R Greene; J G Olson; D B Fishbein; M Olsen-Rasmussen; B P Holloway; E H George
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

8.  Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis.

Authors:  J E Dawson; B E Anderson; D B Fishbein; J L Sanchez; C S Goldsmith; K H Wilson; C W Duntley
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

10.  The relationship between lupus anticoagulants and antibodies to phospholipid.

Authors:  D A Triplett; J T Brandt; K A Musgrave; C A Orr
Journal:  JAMA       Date:  1988 Jan 22-29       Impact factor: 56.272

View more
  15 in total

Review 1.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

2.  Epidemiology of ehrlichiosis and anaplasmosis among American Indians in the United States, 2000-2007.

Authors:  Arianne M Folkema; Robert C Holman; F Scott Dahlgren; James E Cheek; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

Review 3.  Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells.

Authors:  Yasuko Rikihisa
Journal:  Nat Rev Microbiol       Date:  2010-04-07       Impact factor: 60.633

4.  Western immunoblotting analysis of the antibody responses of patients with human monocytotropic ehrlichiosis to different strains of Ehrlichia chaffeensis and Ehrlichia canis.

Authors:  S M Chen; L C Cullman; D H Walker
Journal:  Clin Diagn Lab Immunol       Date:  1997-11

5.  Divergent interactions of Ehrlichia chaffeensis- and Anaplasma phagocytophilum-infected leukocytes with endothelial cell barriers.

Authors:  Jinho Park; Kyoung-Seong Choi; Dennis J Grab; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Serologic diagnosis of human monocytic ehrlichiosis by immunoblot analysis.

Authors:  P Brouqui; C Lecam; J Olson; D Raoult
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

7.  Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis.

Authors:  J S Dumler; S M Chen; K Asanovich; E Trigiani; V L Popov; D H Walker
Journal:  J Clin Microbiol       Date:  1995-07       Impact factor: 5.948

8.  Serologic evidence for human ehrlichiosis in Africa.

Authors:  P Brouqui; C Le Cam; P J Kelly; R Laurens; A Tounkara; S Sawadogo; L Gondao; B Faugere; J Delmont
Journal:  Eur J Epidemiol       Date:  1994-12       Impact factor: 8.082

Review 9.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

10.  Naturally occurring Ehrlichia chaffeensis infection in two prosimian primate species: ring-tailed lemurs (Lemur catta) and ruffed lemurs (Varecia variegata).

Authors:  Cathy V Williams; Jan L Van Steenhouse; Julie M Bradley; Susan I Hancock; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  Emerg Infect Dis       Date:  2002-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.